| Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality N Tamaki, T Kimura, SI Wakabayashi, T Umemura, M Kurosaki, ... Alimentary Pharmacology & Therapeutics 60 (1), 61-69, 2024 | 2 | 2024 |
| Multi-organ linkage pathophysiology and therapy for NAFLD and NASH T Kimura, T Yamazaki, GR Estrela Frontiers in Endocrinology 15, 1418066, 2024 | | 2024 |
| FRI-237 Natural history of lean and non-lean metabolic dysfunction associated steatotic liver disease S Wakabayashi, N Tamaki, T Kimura, T Umemura, M Kurosaki Journal of Hepatology 80, S478-S479, 2024 | | 2024 |
| Case of severe alcoholic hepatitis following acute pancreatitis T Yokoyama, T Iwadare, Y Yamashita, A Momose, H Ikeuchi, S Kondo, ... Clinical Journal of Gastroenterology, 1-7, 2024 | | 2024 |
| Tu1545 CLINICAL SIGNIFICANCE OF SERUM C-REACTIVE PROTEIN LEVELS FOR PREDICTING LENVATINIB-TREATED UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN JAPAN T Okumura, T Kimura, T Iwadare, H Kobayashi, S Wakabayashi, ... Gastroenterology 166 (5), S-1723-S-1724, 2024 | | 2024 |
| Has MetALD met the presumption? Authors' reply N Tamaki, T Kimura, SI Wakabayashi, T Umemura, N Izumi, R Loomba, ... Alimentary Pharmacology & Therapeutics, 2024 | | 2024 |
| Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD T Iwadare, T Kimura, H Kunimoto, T Okumura, SI Wakabayashi, ... Frontiers in Endocrinology 15, 1329294, 2024 | | 2024 |
| Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease T Iwadare, T Kimura, T Okumura, S Wakabayashi, T Nakajima, S Kondo, ... Communications Medicine 4 (1), 73, 2024 | | 2024 |
| Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease SI Wakabayashi, N Tamaki, T Kimura, T Umemura, M Kurosaki, N Izumi Journal of Gastroenterology, 1-10, 2024 | 2 | 2024 |
| Advancements in the Treatment Landscape of Hepatocellular Carcinoma T Kimura Cancers 16 (5), 1054, 2024 | | 2024 |
| Predictive Insights Into Exocrine Pancreatic Insufficiency in Chronic Pancreatitis and Autoimmune Pancreatitis: A Decision Tree Approach T Tanaka, T Kimura, S Wakabayashi, T Okamura, S Shigeto, N Tanaka, ... Pancreas 53 (3), e227-e232, 2024 | | 2024 |
| Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease N Tamaki, SI Wakabayashi, T Kimura, Y Yasui, K Tsuchiya, H Nakanishi, ... Hepatology Research, 2024 | 3 | 2024 |
| Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease T Kimura, T Iwadare, S Wakabayashi, S Kuldeep, T Nakajima, ... Liver International 44 (2), 483-496, 2024 | | 2024 |
| Thrombospondin 2 in Hepatitis B: A Prognostic Insight into Hepatocellular Carcinoma Risk During Nucleos (t) ide Analog Therapy T Okumura, T Kimura, Y Ichikawa, T Iwadare, S Wakabayashi, ... | | 2023 |
| Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study T Okumura, T Kimura, T Iwadare, S Wakabayashi, H Kobayashi, ... Cancers 15 (22), 5343, 2023 | | 2023 |
| Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome T Iwadare, T Kimura, A Sugiura, R Takei, M Kamakura, S Wakabayashi, ... Heliyon 9 (11), 2023 | 2 | 2023 |
| GLYCEMIC CONTROL TARGET ASSOCIATED WITH A LOWER RISK OF LIVER-RELATED AND CARDIOVASCULAR EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE N Tamaki, S Wakabayashi, T Kimura, Y Yasui, K Tsuchiya, H Nakanishi, ... HEPATOLOGY 78, S965-S965, 2023 | | 2023 |
| O-GLYCOSYLATED MIDDLE-HEPATITIS B SURFACE ANTIGEN AS A NEW POTENTIAL BIOMARKER FOR CHRONIC HEPATITIS B: ASSOCIATION WITH HEPATOCELLULAR CARCINOMA AND QUANTITATIVE CHANGES WITH … T Okumura, S Joshita, T Iwadare, H Kobayashi, S Wakabayashi, ... HEPATOLOGY 78, S435-S436, 2023 | | 2023 |
| Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos (t) ide analogue therapy in hepatitis B patients T Okumura, S Joshita, T Iwadare, S Wakabayashi, H Kobayashi, ... Journal of Viral Hepatitis 30 (9), 731-739, 2023 | 4 | 2023 |
| HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population T Okumura, S Joshita, T Yamazaki, T Iwadare, S Wakabayashi, ... Human Immunology 84 (8), 401-407, 2023 | 2 | 2023 |
